FDA Inspection 1002463 — Allergan Pharmaceuticals Ireland
The FDA completed an inspection of Allergan Pharmaceuticals Ireland on Dec 16, 2016 in Westport. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 16, 2016
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Westport (Ireland)
Citations
| ID | CFR | Description |
|---|---|---|
| 1433 | 21 CFR 211.42(c)(10)(iii) | Air Supply |
| 2026 | 21 CFR 211.192 | Quality control unit review of records |